Venus Corp.'s trial balance at December 31, 20x7 is properly adjusted except for the income tax expense adjustment.

Venus Corp.

Trial Balance

December 31, 20x7

Dr.Cr.

Cash$ 914103

Accounts receivable (net) 3920729

Inventory 3230088

Property, plant, and equipment (net)11330972

Accounts payable and accrued liabilities$2682953

Income taxes payable 926394

Future income tax liability 101571

Common stock 4537207

Contributed surplus 3629878

Retained earnings, Jan 1, 20x7 6297817

Net sales and other revenues 16740174

Costs and expenses 13652194

Income tax expenses 1867662

$34916098 $34916098

Other financial data for the year ended December 31, 20x7:

1. Included in accounts receivable is $770078 due from a customer and payable in quarterly instalments of $192519.5. The first payment is not due until December 29, 20x9.

2. The balance in the future income tax liability account relates to a temporary difference that arose in a prior year, of which $16726 is classified as a current liability.

3. Throughout the year, estimated tax of $526107 was included in income taxes payable. At the end of the year income tax expense was determined to be $1867662,the income taxes payable account has not been adjusted yet. As at Dec 31, 20x7, the income taxes for the current year have not been paid.

In Venus's December 31, 2017 statement of financial position, what is the current liabilities total?